Chronic graft-versus-host disease: a prospective cohort study.
about
Thrombocytopenia and hemostatic disorders in chronic graft versus host disease.Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHDComparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.Mesenchymal stem cell as salvage treatment for refractory chronic GVHDChronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.Biomarkers in chronic graft-versus-host diseaseCenter for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohortEarly and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host diseaseExtracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortalityOverlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium studyImpact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.Chronic graft-versus-host disease: where is promise for the future?Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.Therapy of chronic graft-versus-host disease.GVHD: a continuing barrier to the safety of allogeneic transplantationImpact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study.Graft-vs-host disease following allogeneic hematopoietic cell transplantation.Concise review: the bone marrow niche as a target of graft versus host disease.Evolving concepts in prognostic scoring of chronic GvHD.B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality.Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria.Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus.Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children.New classification of chronic GVHD: added clarity from the consensus diagnoses.
P2860
Q33385836-2F77B579-D5D3-4715-90F0-0B0E91DF6F5DQ33591662-399DCE86-77E5-4035-BF8E-B30C6A019368Q34279929-4A3E2C2A-40DF-4EFE-9A72-9950454E1570Q34562177-5AE9A882-9B5A-4587-93CE-05FB29468D1CQ35067642-5FBEAF38-2D96-4C14-A5B7-1ED366D262E8Q35094374-AC42AF63-88FE-40C4-A719-73B4CAD8679EQ35177449-A5CEE846-CBB6-47F3-9AED-1176D4CC247AQ35300908-B7FC86DC-FE63-4BB7-896A-8D6157F0862DQ35483810-191E384A-1321-40B9-9894-F1520FD5E0BAQ35485880-E7729D78-6E3F-4112-BB03-5F6948DEE1F2Q35495340-324C7F6D-9CBE-4F40-8F87-69BCC04B0059Q35528671-BC6AF3FE-E3AA-47E9-BB56-6660FDB958FAQ35794478-3F8AA6E7-A99F-4E15-B678-82713391C17BQ35849241-F2884A6E-728B-4DA6-9AA0-6492EE5F0F88Q36180596-E38A1813-85F5-4A05-9B73-CB393CCB2390Q36675937-8DDEEA56-DBD5-4B10-AEBC-AD1348DD1654Q37173479-926CCA59-4C89-4157-9F9E-0BDEA73D5547Q37369447-20600281-6AD9-4403-8C0C-0F6E60A0CBD6Q37617192-34F83254-3DE1-45E9-8A7A-3B1ABD75177BQ37942818-C0AD4511-0901-4643-89EA-5654043E96B5Q38192559-DEF2E064-C411-4122-8894-719830FC0B1FQ38739174-353DCDC0-AC54-48DC-AEC6-31A2257C998DQ38798545-82499F1A-65CB-40DB-B37A-0C2FD6A50E9CQ41554713-1493B884-FEC8-45EC-B100-CA80D7E598D0Q43413019-A9F26910-31B3-4C5C-86EF-90C53CEA80A6Q46890990-B5E820C4-A494-451D-A7C0-2EB55FD88192Q53453729-A6C8FA99-5DC9-45F6-9A45-21FF874AE902
P2860
Chronic graft-versus-host disease: a prospective cohort study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Chronic graft-versus-host disease: a prospective cohort study.
@en
Chronic graft-versus-host disease: a prospective cohort study.
@nl
type
label
Chronic graft-versus-host disease: a prospective cohort study.
@en
Chronic graft-versus-host disease: a prospective cohort study.
@nl
prefLabel
Chronic graft-versus-host disease: a prospective cohort study.
@en
Chronic graft-versus-host disease: a prospective cohort study.
@nl
P2093
P356
P1476
Chronic graft-versus-host disease: a prospective cohort study.
@en
P2093
Daniel J Weisdorf
Linda J Burns
Margaret L Macmillan
Mukta Arora
Stella M Davies
Todd E Defor
Wesley J Miller
P356
10.1053/BBMT.2003.50003
P577
2003-01-01T00:00:00Z